(BWIN) The Baldwin Insurance - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05589G1022
BWIN EPS (Earnings per Share)
BWIN Revenue
BWIN: Personal Insurance, Commercial Insurance, Risk Management, Employee Benefits
The Baldwin Insurance Group, Inc. (BWIN) is a leading independent insurance distribution firm in the United States, providing a comprehensive suite of insurance and risk management solutions to individuals and businesses. The companys diversified business model is structured around three key segments: Insurance Advisory Solutions, Underwriting, Capacity & Technology Solutions, and Mainstreet Insurance Solutions.
The Insurance Advisory Solutions segment caters to the complex insurance needs of high-net-worth individuals and businesses, offering private risk management, commercial risk management, employee benefits, and Medicare insurance solutions. Meanwhile, the Underwriting, Capacity & Technology Solutions segment leverages its MGA platform to develop and distribute technology-enabled insurance products across personal, commercial, and professional lines.
The Mainstreet Insurance Solutions segment serves individuals and businesses in local communities, providing personal insurance, commercial insurance, and life and health solutions. Additionally, this segment offers reinsurance brokerage services and consultation for government assistance programs, including traditional Medicare and Medicare advantage, as well as affordable care act solutions.
With a strong presence in the US insurance market, The Baldwin Insurance Group, Inc. has established a network of primarily independent contractor agents to deliver its services. The companys evolution is marked by its rebranding from BRP Group, Inc. to The Baldwin Insurance Group, Inc. in May 2024, reflecting its growth and expansion since its founding in 2011.
Analyzing the
From a fundamental perspective, The Baldwin Insurance Group, Inc. has a market capitalization of $2.72 billion and a forward Price-to-Earnings (P/E) ratio of 21.32. However, the companys current Return on Equity (RoE) stands at -5.38%, indicating a challenging period for the company in terms of profitability.
Forecasting the future performance of BWIN using both
Additional Sources for BWIN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BWIN Stock Overview
Market Cap in USD | 2,735m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Insurance Brokers |
IPO / Inception | 2019-10-24 |
BWIN Stock Ratings
Growth Rating | 37.0 |
Fundamental | 30.6 |
Dividend Rating | 0.0 |
Rel. Strength | 2.56 |
Analysts | 3.75 of 5 |
Fair Price Momentum | 39.28 USD |
Fair Price DCF | 10.14 USD |
BWIN Dividends
Currently no dividends paidBWIN Growth Ratios
Growth Correlation 3m | -68.8% |
Growth Correlation 12m | -30% |
Growth Correlation 5y | 38.9% |
CAGR 5y | 19.49% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.06 |
Alpha | 17.11 |
Beta | 0.866 |
Volatility | 41.52% |
Current Volume | 2397.6k |
Average Volume 20d | 657k |
As of June 25, 2025, the stock is trading at USD 44.54 with a total of 2,397,576 shares traded.
Over the past week, the price has changed by +17.43%, over one month by +14.50%, over three months by -2.79% and over the past year by +29.10%.
Neither. Based on ValueRay´s Fundamental Analyses, The Baldwin Insurance is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.64 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BWIN is around 39.28 USD . This means that BWIN is currently overvalued and has a potential downside of -11.81%.
The Baldwin Insurance has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold BWIN.
- Strong Buy: 3
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 1
According to our own proprietary Forecast Model, BWIN The Baldwin Insurance will be worth about 45.1 in June 2026. The stock is currently trading at 44.54. This means that the stock has a potential upside of +1.32%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 46.5 | 4.4% |
Analysts Target Price | 46.5 | 4.4% |
ValueRay Target Price | 45.1 | 1.3% |